Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer

NCT06843954 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

157

Enrollment

OTHER

Sponsor class

Conditions

Colo-rectal Cancer

Interventions

DRUG: Bevacizumab

Sponsor

Mohammed Mahmood Mohammed